SCHEMBL5636754

SCHEMBL5636754

Nc1c(F)cccc1C(=O)CCCCl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.42
CES1 P23141 3/20 0.42
BCHE P06276 1/20 0.42
CTNNB1 P35222 5/20 0.41
WNT3A P56704 5/20 0.41
DRD2 P14416 3/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
ALDH1A1 P00352 1/20 0.38
ALOX15 P16050 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ALB P02768 1/20 0.36
PTPN1 P18031 1/20 0.36
ERCC5 P28715 1/20 0.36
FEN1 P39748 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29391353 0.83 CTNNB1 (0.57) CES2CES1CTNNB1WNT3ADRD2
SCHEMBL1050668 0.83 CTNNB1 (0.57) CES2CES1CTNNB1WNT3ADRD2
SCHEMBL7545488 0.81 CD44 (0.41) CTNNB1WNT3ADRD2ALDH1A1ERCC5
Hydrochloric Acid SCHEMBL9864094 0.79 CTNNB1 (0.40) CTNNB1WNT3ADRD2ALDH1A1ERCC5
SCHEMBL5661970 0.78 CTNNB1 (0.55) CES2CES1CTNNB1WNT3ADRD2
SCHEMBL5659865 0.77 CTNNB1 (0.54) CES2CES1CTNNB1WNT3ADRD2
SCHEMBL5658640 0.77 CTNNB1 (0.54) CES2CES1CTNNB1WNT3ADRD2
SCHEMBL9118756 0.76 CES2 (0.47) CES2CES1BCHEALDH1A1ALOX15
SCHEMBL27203892 0.76 CES2 (0.57) CES2CES1BCHECTNNB1WNT3A
SCHEMBL5415859 0.76 GAA (0.44) ALDH1A1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39679-E1 Substituted heterocycle fused gamma-carbolines BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-06-05 US disclosed
EP-1192165-B1 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-09-22 EP disclosed
US-6713471-B1 SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-03-30 US disclosed
CN-1370176-A Subsstituted heterocycle fused gamma-carbolines BRISTOL MYERS SQUIBB CO (US) 2002-09-18 CN disclosed
EP-1192165-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES Bristol-Myers Squibb Pharma Company (US) 2002-04-03 EP disclosed
WO-2000077010-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES DU PONT PHARMACEUTICALS COMPANY (US) 2000-12-21 WO disclosed